Skip to main content
TipRanks
Go Ultimate75% OFF

Argenx Se (1AEA) Stock Price & Analysis

19 Followers

1AEA Stock Chart & Stats

€865.00-€10.00(-1.14%)
At close: 5:30 PM GMT+1
€750€800€850€900Jul 30Aug 24Sep 4Sep 14Oct 8Oct 20
Day’s Range
EUR 840.00 - EUR 865.00
52-Week Range
EUR 560.00 - EUR 920.00
Previous Close
EUR 875.00
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 55.24B
Enterprise Value
EUR 54.62B
Total Cash (Recent Filing)
EUR 5.18B
Total Debt (Recent Filing)
EUR 47.00M
Price to Earnings (P/E)
45.5
Beta
0.30
Next Earnings
Feb 25, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Rapid Product Growth And Margins

Sustained product growth, driven by increasing patients served, shows expanding commercial adoption rather than reliance on a single short-term event. Strong operating margins indicate that revenue is scaling faster than expenses, supporting reinvestment and potentially durable earnings growth.

Exceptional Balance Sheet Strength

Minimal leverage and a large equity base give argenx substantial flexibility to fund research, commercial expansion and acquisitions without depending heavily on debt markets. This financial capacity is especially valuable for biotechnology programs that require sustained investment before generating revenue.

Broad Commercial And Pipeline Expansion

A growing pipeline combined with multiple potential launches can diversify argenx beyond its current marketed indications and extend its commercial platform. Additional labels, delivery options and disease areas create several avenues for patient growth and reduce dependence on one development catalyst.

Bears Say

Sharp Operating Expense Increase

The planned expense step-up materially raises the investment required to support Forte, FB102, commercial infrastructure and the broader pipeline. Even if strategically justified, this spending can pressure margins and cash generation if launches, approvals or clinical outcomes take longer than expected.

Clinical Development Setbacks

Stopping UNITY for futility removes a development opportunity and demonstrates that parts of the pipeline may not translate into successful products. Such outcomes can narrow future indication breadth, reduce the return on research spending and increase reliance on the remaining programs.

Uneven Cash Conversion History

Although cash flow improved substantially in 2025, the multiyear record remains inconsistent and operating cash flow did not fully match reported earnings. Continued investment and expansion therefore require close execution to ensure accounting profitability converts into durable internally generated cash.

Argenx Se News

1AEA FAQ

What was Argenx Se’s price range in the past 12 months?
Argenx Se lowest stock price was €560.00 and its highest was €920.00 in the past 12 months.
What is Argenx Se’s market cap?
Argenx Se’s market cap is €55.24B.
When is Argenx Se’s upcoming earnings report date?
Argenx Se’s next earnings report is estimated for Feb 25, 2027 (not yet confirmed), which is in 100 days.
How were Argenx Se’s earnings last quarter?
Argenx Se released its earnings results on Oct 22, 2026. The company reported €7.077 earnings per share for the quarter, missing the consensus estimate of €7.245 by -€0.169.
Is Argenx Se overvalued?
According to Wall Street analysts Argenx Se’s price is currently Undervalued.
Does Argenx Se pay dividends?
Argenx Se does not currently pay dividends.
What is Argenx Se’s EPS estimate?
Argenx Se’s EPS estimate is 7.26.
How many shares outstanding does Argenx Se have?
Argenx Se has 62,886,074 shares outstanding.
What happened to Argenx Se’s price movement after its last earnings report?
Argenx Se reported an EPS of €7.077 in its last earnings report, missing expectations of €7.245. Following the earnings report the stock price went up 1.29%.
Which hedge fund is a major shareholder of Argenx Se?
Hedge funds hold Argenx Se shares: the largest hedge-fund position in Argenx Se is 1,537,116,773 shares, and hedge funds decreased their holdings by 11.6K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology